Aster DM Healthcare Limited has informed the Exchange regarding Board meeting held on July 30, 2025.
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Smallcap 250 and 1.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aster DM Healthcare reported its Q1 FY26 (quarter ended June 30, 2025) unaudited results with an unmodified auditor opinion from Deloitte Haskins & Sells. Consolidated revenue from operations rose to INR 1,077.87 crores from INR 1,001.87 crores a year earlier (~7.6% growth), while profit from continuing operations after tax grew to INR 93.56 crores from INR 81.00 crores (~15.5% growth). Standalone revenue grew to INR 613.04 crores with a PAT of INR 80.59 crores. The company booked an exceptional expense of INR 4.39 crores for professional fees related to a merger and a proposed acquisition. The Board fixed August 28, 2025 as the record date for the INR 1 per share final dividend and the 17th AGM on September 4, 2025. It also approved buying Block-D assets of Aster Whitefield Hospital from its wholly owned subsidiary AMHPL for up to INR 80 crores, classified as a related party transaction at arm's length.
Steady mid-single-digit revenue growth and double-digit profit growth from continuing operations signal operational stability post-GCC separation. The INR 80 crore inter-company asset transfer is internal restructuring and unlikely to materially affect shareholders, while the INR 1 final dividend and pending merger/acquisition activity may influence near-term stock sentiment.